Physician profile
Marc D Liang
NPI 1063572220
$6,985.13
in general payments reported to CMS, 2019-2025
7 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $1,855 · 2021: $163 · 2022: $1,076 · 2023: $1,580 · 2024: $741 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697 · Travel and Lodging: $766 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.40 |
| Travel and Lodging | $766.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $223.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $4,031.26 | 2019-2025 | |
| Abbvie INC. | $853.34 | 2023-2025 | |
| Galderma Laboratories, L.P. | $733.15 | 2019-2024 | Dysport |
| Sientra, INC. | $599.79 | 2019-2022 | |
| Merz North America, INC. | $395.79 | 2019-2025 | |
| Allergan, INC. | $321.68 | 2019-2022 | |
| Mentor Worldwide LLC | $50.12 | 2023-2024 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.